US

Ming Zhang

This inventor holds 0 USPTO granted patents, plus 7 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Zhang. Retrieved from https://idiyas.com/inventor/ming-zhang-sx0cvd94

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovative Journey of Inventor Ming Zhang

Introduction: Ming Zhang is a notable figure in the landscape of innovation and research in the United States. Although he has not yet secured any patents, his contributions through his work at established companies like Amgen Inc. and Iview Therapeutics, Inc. showcase his commitment to the advancement of technology and healthcare.

Latest Patents: Currently, Ming Zhang holds no patents. However, his experiences and roles in influential companies indicate a potential for future inventions that could impact various sectors.

Career Highlights: Throughout his career, Ming Zhang has made significant strides in the health and biotechnology fields. His tenure at Amgen Inc. has equipped him with valuable knowledge in biopharmaceuticals, while his experience at Iview Therapeutics, Inc. demonstrates his involvement in innovative therapies and drug development.

Collaborations: Ming Zhang has worked alongside talented teams in both Amgen Inc. and Iview Therapeutics, Inc., contributing to collaborative projects that aim at discovering new therapeutic strategies. These collaborations highlight his ability to work well in interdisciplinary environments to drive innovation.

Conclusion: While Ming Zhang has yet to file any patents, his intriguing career and experiences in leading biotech firms suggest a promising future in innovation. His journey reflects the potential that lies in the dedication to research and development, and it will be exciting to see how his career evolves in the coming years.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…